search button
Open Access

The composition and variation of the BCR CDR3s in gastric cancer

  • Authors:
    • Song Liu
    • Ying Zhu
    • Lie‑Wen Lin
    • Shun‑Kai Ding
    • Xiao‑Cong Lin
    • Ke‑Li Zhong
    • Kai Pan
    • Yong Dai

  • View Affiliations

  • Published online on: May 9, 2018     https://doi.org/10.3892/ol.2018.8677
  • Pages: 239-246

  • Copyright: © Liu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Abstract

Gastric cancer (GC) is the fourth most common type of cancer and the second most common cause of cancer‑associated mortality worldwide. B cell‑associated autoantibodies against tumor‑associated antigens are attractive biomarkers for the development of noninvasive serological tests for the early detection of cancer. This is due to their specificity and stability in the sera. In the present study multiplex polymerase chain reaction and Illumina high‑throughput sequencing (HTS) was used to study the composition and variation of the B cell receptor (BCR) complimentary‑determining region 3 (CDR3) in GC. The peripheral blood, cancer tissues and peri‑cancer tissues were included from 7 patients with GC. On average there was a total of 403,959 CDR3 sequences, with 72,367 unique CDR3 nt sequences and 61,709 unique CDR3 aa sequences per sample identified, which are critical for further understanding the BCR repertoire in GC. The details of GC CDR3s may accelerate the screening process for possible new autoantigens and may provide additional information necessary for generating effective B cell targeted diagnosis and therapeutic strategies.
View Figures
View References

Related Articles

Journal Cover

July-2018
Volume 16 Issue 1

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

  • Journal Metrics
  • Impact Factor: 2.5
  • Ranked Oncology
    (total number of cites)
  • CiteScore: 5.7
  • CiteScore Rank: Q2: #139/404 Oncology
  • Source Normalized Impact per Paper (SNIP): 0.574
  • SCImago Journal Rank (SJR): 0.644
International Symposium on Molecular Medicine Conference Banner
The Cancer Story
World Congress on Advances in Oncology and International Symposium on Molecular Medicine Conference Banner
World Academy Of Sciences Banner
Heyday Road Banner

0

Copy and paste a formatted citation
x
Spandidos Publications style
Liu S, Zhu Y, Lin LW, Ding SK, Lin XC, Zhong KL, Pan K and Dai Y: The composition and variation of the BCR CDR3s in gastric cancer. Oncol Lett 16: 239-246, 2018.
APA
Liu, S., Zhu, Y., Lin, L., Ding, S., Lin, X., Zhong, K. ... Dai, Y. (2018). The composition and variation of the BCR CDR3s in gastric cancer. Oncology Letters, 16, 239-246. https://doi.org/10.3892/ol.2018.8677
MLA
Liu, S., Zhu, Y., Lin, L., Ding, S., Lin, X., Zhong, K., Pan, K., Dai, Y."The composition and variation of the BCR CDR3s in gastric cancer". Oncology Letters 16.1 (2018): 239-246.
Chicago
Liu, S., Zhu, Y., Lin, L., Ding, S., Lin, X., Zhong, K., Pan, K., Dai, Y."The composition and variation of the BCR CDR3s in gastric cancer". Oncology Letters 16, no. 1 (2018): 239-246. https://doi.org/10.3892/ol.2018.8677